Medicrea International SAの売上総利益
Medicrea International SAの売上総利益 は何ですか。
Medicrea International SAの売上総利益 は77.83%です。
売上総利益 の定義は何ですか。
売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
LSEのセクタHealth Careにおける売上総利益 の企業と比べるMedicrea International SA
Medicrea International SAは何をしますか。
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Medicrea International SAと類似の売上総利益
- AudioEye Incの売上総利益 は77.73%です。
- Compagnie Financiere de Neufcour S.Aの売上総利益 は77.76%です。
- FS KKR Capital Corpの売上総利益 は77.76%です。
- Chaparralの売上総利益 は77.76%です。
- Global Venturesの売上総利益 は77.76%です。
- Oriental Explorerの売上総利益 は77.82%です。
- Medicrea International SAの売上総利益 は77.83%です。
- Career Pointの売上総利益 は77.84%です。
- Apollo Investmentの売上総利益 は77.84%です。
- Medicrea International SAの売上総利益 は77.84%です。
- Microstrategyの売上総利益 は77.85%です。
- Veritone Incの売上総利益 は77.85%です。
- Da Senの売上総利益 は77.86%です。